Objective To evaluate the usefulness of 
Introduction

Tuberculosis (TB) is a major infectious cause of morbidity and mortality throughout the world. Tuberculosis (TB) case rates continue to decline in most industrialized countries, but persons with latent tuberculosis infection (LTBI) constitute a vast pool of individuals who may develop TB, particularly when the immune response is suppressed. When patients with active TB are detected in a community tertiary hospital without a special TB ward, nosocomial infection among health care workers and other inpatients becomes a major problem. In such a situation, it is important to isolate health care workers with LTBI from the index case showing active TB to prevent the spread of nosocomial infection. Accurate diagnosis and treatment of LTBI, therefore, have become increasingly important goals of TB control to prevent nosocomial infection of TB (1).
Unfortunately, the standard diagnostic tool for the diagnosis of LTBI has many well known limitations. The sensitivity of the tuberculin skin test (TST) is low for the diagnosis of active TB infections. Specificity is limited by crossreactivity of the purified protein derivatives (PPD) with the Bacillus Calmette-Guerin (BCG) vaccine and with most nontuberculous mycobacteria
. Moreover, the sensitivity of TST is low in immunosuppressed patients in whom the risk of progression to TB is high. As a result, a significant prevalence of false-negative results is produced among such a population (3) . Despite (11, 12) Fig. 1 
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Results
Demographics of contact investigators
pharmacologists. Two subjects (1%) had clinical symptoms at the time of contact investigation. One hundred forty-eight subjects (78%) had a history of BCG vaccination. One hundred twelve subjects (59%) received the first vaccination at ages three to six years old, 78 (41%) at ages seven to twelve years old. The past history of TST was positive ( 10 mm maximum length of erythema) in 81 subjects (43%) and negative in 109 (57%) (<9 mm maximum length of erythema). None of the subjects had used mask equipment during contact with the index cases.
Index cases with pulmonary TB appeared in a community tertiary hospital after admission
There were four index cases in this study. Three of four patients were elderly (over 80 years old) and all had nonrespiratory underlying diseases. All four patients had clinical symptoms such as fever and moderate or severe cough and 5 24 days was required to obtain an appropriate diagnosis after admission. Sputum smear acid-fast bacilli examinations showing infectivity presented as (2+) (3+). Regarding the radiological findings, there were no cavitary lesions or brochiectatic lesions, but there were inhomogeneous infiltration shadows in all cases and it was difficult to distinguish these findings from pneumonia. Final clinical diagnosis was pulmonary TB in three patients, pulmonary TB + tuberculous pleuritis in one.
Contact score and TST positive rate or QFT-2G positive rate
We selected TST positive response as ( 30 mm) because Shigeto et al indicated the possibility of TB infection was high in health care workers showing erythema of 30 mm or more despite previous BCG vaccination (18). The relationship between the contact score and TST positive ( 30 mm) and QFT-2G positive rates is shown in
T a b l e 1 . T h e Re l a t i o n s h i p b e t we e n Co n t a c t S c o r e a n d T S T P o s i t i v e Ra t e o r QF T -2 G P o s it i v e Ra t e positive rate was unchanged with increase in the contact score, the QFT-2G positive rate was significantly increased in the group with a severe contact score compared to that in the groups with a mild or moderate contact score. In addition, the overall TST positive rate (25%) was significantly higher than the overall QFT-2G positive rate (3%). There were no indeterminate QFT-2G results in this study.
Maximum length of erythema for TST and QFT-2G results
The distribution of the maximum length of erythema for the TST and QFT-2G test is shown in
. Although three of five subjects showed a QFT-2G positive response among the group of subjects with a TST positive response ( 30 mm), the remaining two subjects were recognized among the group of subjects with a TST positive response (10 29 mm). There was no relationship between the maximum length of erythema for TST and the results of QFT-2G.
Clinical findings of contact subjects with a positive response for QFT-2G
The clinical findings of contact subjects with a positive response for QFT-2G are shown in Table 2 . Three subjects were nurses and two were doctors. Although one of these subjects had no BCG vaccination history and no TST positive history, she also converted from negative to positive TST reaction after contact with the index case. A preventive antituberculous drug (isoniazid: 400 mg/day for six months) was administered to the five subjects who had positive QFT-2G responses. Subsequently, there was no active TB infection in any of these subjects. Regarding the QFT-2G transitional change during treatment, two of the four subjects converted from positive to negative response on QFT-2G six and nine months, respectively, after the initiation of treatment. (10, (23) (24) (25) 
Discussion
An accurate diagnosis of latent tuberculosis infection (LTBI) among health care workers is important to prevent nosocomial infection with
QFT-2G response, there was no progression to active TB in any cases. The QFT-2G test is technically feasible to perform and is likely to be a more accurate method of diagnosing LTBI than the TST. The improved specificity of the QFT-2G test will reduce the number of false-positive diagnoses of LTBI in BCG-vaccinated individuals.
To T a b l e 2 . Cl i n i c a l F i n d i n g s o f Co n t a c t I n v e s t i g a t i o n s i n S u b j e c t s wi t h a P o s i t i v e QF T -2 G Re s p o n s 
